Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Pro soccer striker Marlee Fray is leading the charge for the next generation of college sports stars with diabetes in new NIL ...

In the ruins of a health-care system, many medical facilities have become graveyards. Doctors continue to deliver lifesaving ...

The UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early ...

Afon Technology has been a leader in diabetes innovation with its GlucowearTM device, the world’s first non-invasive glucose ...

Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Biolinq received $100 million in a Series C funding round to bring its wearable for patients with diabetes to market, the ...